Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 1/2 4Phase 1 3Phase EARLY_PHASE1 1Phase 3 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 3NIH 2INDUSTRY 2

Study Type

Interventional 3

Sponsor

Cancer Type

Other solid neoplasm 1Myeloid 1Dermatologic 1

Conditions

Myelodysplastic Syndromes 1Melanoma 1Graft vs Host Disease 1Advanced Solid Tumors 1

Interventions

Cyclophosphamide 416Radiotherapy 276fludarabine 238Gemcitabine 211Cisplatin 203Nivolumab 184pembrolizumab 183Paclitaxel 176Carboplatin 168Magnetic Resonance Spectroscopy 166fludarabine phosphate 156Irinotecan 135Bevacizumab 133Cytarabine 128Specimen Handling 124Capecitabine 124Temozolomide 123Radiosurgery 118Docetaxel 116Biopsy 116Ipilimumab 113Dexamethasone 113Radiation 111Oxaliplatin 110Fluorouracil 110Rituximab 108Etoposide 108Filgrastim 99Lenalidomide 98Everolimus 96

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × OTHER × Interferon-gamma × Clear all
NCT04328714 2026-02-13

Interferon γ-Primed Mesenchymal Stromal Cells as Prophylaxis for Acute Graft v Host Disease

Emory University

Phase 1 Terminated
4 enrolled
Myeloid

Graft vs Host Disease, Myelodysplastic Syndromes

NCT02614456 2019-11-29

Combination of Interferon-gamma and Nivolumab for Advanced Solid Tumors

Fox Chase Cancer Center

Phase 1 Completed
26 enrolled
Other solid neoplasm

Advanced Solid Tumors

NCT00004016 2013-06-06

Interferon Gamma in Treating Patients With Recurrent or Metastatic Melanoma or Other Solid Tumors

University of Rochester

Phase 1 Completed
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡